First Page | Meta Content | |
---|---|---|
![]() | Document Date: 2013-10-09 09:36:48Open Document File Size: 655,51 KBShare Result on FacebookCityBrussels / /ContinentEurope / /CountryGermany / Belgium / Austria / Netherlands / Italy / Bulgaria / United Kingdom / Sweden / Greece / / /IndustryTermInsurance/indemnisation / investigational medicinal product / auxiliary medicinal products / ultra orphan medicinal products / pragmatic and fast solution / auxiliary medicinal product / pharmaceutical products / medicinal products / insurance/indemnity / health technology assessments / insurance requirements / /MedicalConditionfastly-progressing diseases / rare diseases / disease / rare and ultra rare diseases / rare and ultra-rare diseases / injury / diseases / MS / /OrganizationWorld Health Organization / National Competent Authority / European Confederation of Pharmaceutical Entrepreneurs / European Commission / IFPMA / Ethical Committee / European Union / EMIG / / /Positioninvestigator / Alexander Natz Secretary General / administrator / General / legal representative / /ProgrammingLanguageEC / /URLwww.eucope.org / /SocialTag |